1. Home
  2. CPRX vs RDW Comparison

CPRX vs RDW Comparison

Compare CPRX & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.45

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

RDW

Redwire Corporation

HOLD

Current Price

$12.29

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPRX
RDW
Founded
2002
2020
Country
United States
United States
Employees
N/A
1410
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
CPRX
RDW
Price
$31.45
$12.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$35.00
$13.71
AVG Volume (30 Days)
1.7M
39.1M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
28.24
N/A
EPS
0.50
N/A
Revenue
$119,072,803.00
N/A
Revenue This Year
$9.20
$41.68
Revenue Next Year
$10.51
$20.25
P/E Ratio
$62.94
N/A
Revenue Growth
16.39
N/A
52 Week Low
$19.05
$4.87
52 Week High
$32.56
$26.64

Technical Indicators

Market Signals
Indicator
CPRX
RDW
Relative Strength Index (RSI) 71.22 42.84
Support Level $31.25 $7.49
Resistance Level $32.56 $14.55
Average True Range (ATR) 0.04 1.28
MACD -0.09 -0.59
Stochastic Oscillator 70.59 29.31

Price Performance

Historical Comparison
CPRX
RDW

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

Share on Social Networks: